摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-环己基-N-甲基-4-[(3,4-二氢-2-氧代-1H-喹唑啉-6-基)氧基]丁酰胺 | 105763-56-2

中文名称
N-环己基-N-甲基-4-[(3,4-二氢-2-氧代-1H-喹唑啉-6-基)氧基]丁酰胺
中文别名
丁酰胺,N-环己基-N-甲基-4-[(1,2,3,4-四氢-2-羰基-6-喹唑啉基)氧代]-
英文名称
N-cyclohexyl-N-methyl-4-[(3,4-dihydro-2-oxo-1H-quinazolin-6-yl)oxy]butyramide
英文别名
N-cyclohexyl-N-methyl-4-[(2-oxo-3,4-dihydro-1H-quinazolin-6-yl)oxy]butanamide
N-环己基-N-甲基-4-[(3,4-二氢-2-氧代-1H-喹唑啉-6-基)氧基]丁酰胺化学式
CAS
105763-56-2
化学式
C19H27N3O3
mdl
——
分子量
345.442
InChiKey
PXDHBHMHUWUNSC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    160-161 °C
  • 沸点:
    541.8±50.0 °C(Predicted)
  • 密度:
    1.20±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    25
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    70.7
  • 氢给体数:
    2
  • 氢受体数:
    3

SDS

SDS:3d6fd6cbf5724377069eab82a6615c5e
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    N-甲基环己胺 在 palladium on activated charcoal sodium tetrahydroborate 、 氢气 、 sodium carbonate 、 溴甲烯基二甲基溴化铵 作用下, 以 四氢呋喃1,4-二氧六环乙醇N,N-二甲基甲酰胺 为溶剂, 25.0~110.0 ℃ 、344.73 kPa 条件下, 反应 4.0h, 生成 N-环己基-N-甲基-4-[(3,4-二氢-2-氧代-1H-喹唑啉-6-基)氧基]丁酰胺
    参考文献:
    名称:
    Inhibitors of cyclic AMP phosphodiesterase. 1. Analogs of cilostamide and anagrelide
    摘要:
    Evaluation of a series of lactam heterocyclic analogues of cilostamide (2) as inhibitors of cyclic AMP phosphodiesterase derived from both human platelets and rat heart in comparison with their corresponding methoxy-substituted heterocycles has revealed that the N-cyclohexyl-N-methyl-4-oxybutyramide side chain of 2 is an important lipophilic and/or steric pharmacophore. Attachment of this side chain to the parent heterocycle of the potent cyclic AMP phosphodiesterase inhibitor anagrelide (3) afforded the hybrid structure RS-82856 (1), shown to be more potent than either of its progenitors as an inhibitor of cyclic AMP phosphodiesterase or of ADP-induced platelet aggregation. The available in vitro data suggest that 1 possesses potentially useful antithrombotic and cardiotonic properties.
    DOI:
    10.1021/jm00385a011
点击查看最新优质反应信息

文献信息

  • JONES G. H.; VENUTI M. C.; ALVAREZ R.; BRUNO J. J.; BERKS A. H.; PRINCE A+, J. MED. CHEM., 30,(1987) N 2, 295-303
    作者:JONES G. H.、 VENUTI M. C.、 ALVAREZ R.、 BRUNO J. J.、 BERKS A. H.、 PRINCE A+
    DOI:——
    日期:——
  • Inhibitors of cyclic AMP phosphodiesterase. 1. Analogs of cilostamide and anagrelide
    作者:Gordon H. Jones、Michael C. Venuti、Robert Alvarez、John J. Bruno、Andrew H. Berks、Anthony Prince
    DOI:10.1021/jm00385a011
    日期:1987.2
    Evaluation of a series of lactam heterocyclic analogues of cilostamide (2) as inhibitors of cyclic AMP phosphodiesterase derived from both human platelets and rat heart in comparison with their corresponding methoxy-substituted heterocycles has revealed that the N-cyclohexyl-N-methyl-4-oxybutyramide side chain of 2 is an important lipophilic and/or steric pharmacophore. Attachment of this side chain to the parent heterocycle of the potent cyclic AMP phosphodiesterase inhibitor anagrelide (3) afforded the hybrid structure RS-82856 (1), shown to be more potent than either of its progenitors as an inhibitor of cyclic AMP phosphodiesterase or of ADP-induced platelet aggregation. The available in vitro data suggest that 1 possesses potentially useful antithrombotic and cardiotonic properties.
查看更多